Institutional Ownership Ani Pharmaceuticals Inc (ANIP)
This table provides information about the institutional ownership of Ani Pharmaceuticals Inc (ANIP). We have compiled data on the 239 institutions that hold shares in the stock, with a total of 20 Million shares, which have been reported (via 13F filing form) to have a value of $1.36 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Principal Securities, Inc.
Des Moines, IA |
Apr 30, 2025 Q1 2025 |
6
shares
|
$408
0.0% of portfolio
|
Q4 2024
New holding
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
5
shares
|
$340
0.0% of portfolio
|
Q2 2022
Reduced 80.0%
|
|
Stephens Consulting, LLC
Flint, MI |
Apr 17, 2025 Q1 2025 |
5
shares
|
$340
0.0% of portfolio
|
Q1 2025
New holding
|
|
Covestor LTD
Boston, MA |
May 12, 2025 Q1 2025 |
2
shares
|
$136
0.0% of portfolio
|
Q1 2025
Reduced 95.74%
|
|
Cbiz Investment Advisory Services, LLC
|
Jun 03, 2025 Q1 2025 |
2
shares
|
$136
0.0% of portfolio
|
Q4 2024
New holding
|
|
Kiely Wealth Advisory Group, Inc.
Oak Ridge, NC |
Feb 12, 2025 Q4 2024 |
1
shares
|
$68
0.0% of portfolio
|
Q4 2023
New holding
|
|
Bogart Wealth, LLC
|
May 01, 2025 Q1 2025 |
1
shares
|
$68
0.0% of portfolio
|
Q1 2025
Reduced 97.5%
|
|
Huntington National Bank
Columbus, OH |
May 14, 2025 Q1 2025 |
1
shares
|
$68
0.0% of portfolio
|
Q4 2021
New holding
|
|
Ifp Advisors, Inc
|
May 05, 2025 Q1 2025 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|